Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC20H22N2O5 |
InChIKeyPFPVQJAKWPMYDX-UHFFFAOYSA-N |
CAS Registry169322-61-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | US | - | |
Neoplasms | Discovery | US | - | |
Neoplasms | Discovery | US | - | |
Neoplasms | Discovery | US | - |